Grifols, S.A. (GRFS) Social Stream
GRIFOLS SA (GRFS) Price Targets From Analysts
Use the tables below to see what analysts covering GRIFOLS SA think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
GRFS's average price target has moved down $17.38 over the prior 37 months.
Over the past 49 weeks, GRFS's average upside potential has been 19.14%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GRFS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, GRFS's average broker recommendation rating improved by 0.33.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how GRIFOLS SA fares relative to all US stocks, note that its variance in analysts' estimates is lower than 47.18% of that group.
- In terms of how GRIFOLS SA fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 14.4% of that group.
- In terms of how GRIFOLS SA fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 67.66% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GRIFOLS SA's upside potential (average analyst target price relative to current price) is greater than 199.56% of them.
Make investment decisions regarding GRFS using the data that counts. Try POWR Ratings for free.